Number of active trials in Alzheimer's Disease pipeline 2022, by product type
Of the 256 active trials in the Alzheimer's Disease pipeline as of 2022, the vast majority of trials, 215 of them, were for drug therapies. This statistic depicts the number of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type.